development services. With over 75 research sites and more than 100 Principal Investigators, incorporating both stand-alone facilities as well as physician based centers; they are the country’s largest wholly-owned network of clinical trial sites with fully integrated quality systems and a database of over 2.5 million participants. Radiant has conducted more than 14,000 clinical trials across a variety of therapeutic areas.

Their centers all have DEA certification for schedule II-V drugs and have CLIA waivers or CLIA PPMP (Provider Performed Microscopy Procedures) certifications to accommodate on-site lab testing. Additionally, all centers are self-identified with the FDA in support of the new requirements related to the Generic Drug User Fee Amendment (GDUFA). Staff at all of their centers routinely complete GCP and Human Protections training, IATA certification and ongoing training in a multitude of continuing clinical research education topics. Training documentation can be provided upon request for any individual staff member.